Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer
Извор:
Value in Health, 2014, 17, 7, A654-A654Издавач:
- Elsevier Science Inc, New York
DOI: 10.1016/j.jval.2014.08.2385
ISSN: 1098-3015
PubMed: 27202366
WoS: 000346917302419
[ Google Scholar ]Институција/група
TorlakTY - CONF AU - Bekčić, Stana AU - Mitrović, I. AU - Baltezarević, D. AU - Radojević, V. AU - Samardžić, J. AU - Milenković, V. PY - 2014 UR - http://intor.torlakinstitut.com/handle/123456789/408 PB - Elsevier Science Inc, New York C3 - Value in Health T1 - Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer EP - A654 IS - 7 SP - A654 VL - 17 DO - 10.1016/j.jval.2014.08.2385 ER -
@conference{ author = "Bekčić, Stana and Mitrović, I. and Baltezarević, D. and Radojević, V. and Samardžić, J. and Milenković, V.", year = "2014", publisher = "Elsevier Science Inc, New York", journal = "Value in Health", title = "Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer", pages = "A654-A654", number = "7", volume = "17", doi = "10.1016/j.jval.2014.08.2385" }
Bekčić, S., Mitrović, I., Baltezarević, D., Radojević, V., Samardžić, J.,& Milenković, V.. (2014). Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer. in Value in Health Elsevier Science Inc, New York., 17(7), A654-A654. https://doi.org/10.1016/j.jval.2014.08.2385
Bekčić S, Mitrović I, Baltezarević D, Radojević V, Samardžić J, Milenković V. Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer. in Value in Health. 2014;17(7):A654-A654. doi:10.1016/j.jval.2014.08.2385 .
Bekčić, Stana, Mitrović, I., Baltezarević, D., Radojević, V., Samardžić, J., Milenković, V., "Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer" in Value in Health, 17, no. 7 (2014):A654-A654, https://doi.org/10.1016/j.jval.2014.08.2385 . .